Related Experiment Videos
MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria
Abstract:
We reported previously that a synthetic compound, MT-21, induced apoptosis by activating c-Jun-NH2-terminal kinase via the Krs/MST protein, which is activated by caspase-3 cleavage dependent on reactive oxygen species production. Here we examine the activation mechanism of caspase-3, an important cysteine aspartic protease, during MT-21-induced apoptosis. We found that MT-21 activated caspase-3 via caspase-9, but not via caspase-8. In addition, MT-21 induced the release of cytochrome c from the mitochondria that is necessary to activate caspase-9, and this release occurred before a change in membrane potential. This initiation process of MT-21-induced apoptosis was suppressed by overexpression of Bcl-2, which is known to prevent cells from undergoing apoptosis in response to a variety of stimuli. Moreover, when we treated mitochondria isolated from the cells with MT-21, the direct release of cytochrome c from the mitochondria was observed, whereas this effect was not observed in the mitochondria isolated from cells that overexpressed Bcl-2. Other apoptosis-inducing agents known to induce apoptosis via cytochrome c release from the mitochondria failed to release cytochrome c directly from isolated mitochondria. These findings indicate that MT-21 is a possible candidate antitumor agent that is able to induce apoptosis via the direct release of cytochrome c from the mitochondria.
Insights
The compound MT-21 triggers apoptosis by directly releasing cytochrome c from mitochondria, activating caspase-9. This mechanism suggests MT-21 as a potential antitumor agent.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Synthetic compound MT-21 previously shown to induce apoptosis via c-Jun-NH2-terminal kinase.
- Apoptosis is a crucial process regulated by caspases and mitochondrial pathways.
Purpose of the Study:
- To elucidate the specific mechanism of caspase-3 activation in MT-21-induced apoptosis.
- To investigate the role of mitochondrial pathways, including cytochrome c release, in MT-21's apoptotic effects.
Main Methods:
- Investigated caspase-3 activation pathways (caspase-9 vs. caspase-8).
- Analyzed cytochrome c release from mitochondria and its timing relative to mitochondrial membrane potential.
- Utilized Bcl-2 overexpression to assess its inhibitory effect on MT-21-induced apoptosis.
- Examined direct effects of MT-21 on isolated mitochondria.
Main Results:
- MT-21 activates caspase-3 through the caspase-9 pathway, independent of caspase-8.
- MT-21 induces cytochrome c release from mitochondria prior to changes in membrane potential.
- Bcl-2 overexpression significantly suppresses MT-21-induced apoptosis.
- MT-21 directly causes cytochrome c release from isolated mitochondria, a unique observation compared to other agents.
Conclusions:
- MT-21 induces apoptosis via the intrinsic pathway, characterized by direct mitochondrial cytochrome c release.
- The findings support MT-21 as a promising candidate antitumor agent due to its novel apoptotic mechanism.